Factor XIII A (FXIIIA) is a member of the transglutaminase enzyme family that cross-links both intra-and extracellular protein substrates. To prevent undesired cross-linking, FXIIIA is expressed as an inactive zymogen and exists intracellularly as an A 2 homodimer. In plasma, FXIII A 2 is complexed with two protective factor XIII B subunits (A 2 B 2 ) that dissociate upon activation of the zymogen. Based on limited experimental data, activated FXIII was considered a dimer of two catalytically active A subunits. However, accumulating but indirect evidence has suggested activation may lead to a monomeric state instead. In the present study, we employed analytical ultracentrifugation (AUC) to directly explore the oligomerization state of zymogen as well as active FXIIIA in solution. We first confirmed that the zymogen was a FXIIIA 2 dimer. When we activated FXIIIA nonproteolytically (by high mM Ca 2+ ), the protein dissociated to monomers. More importantly, FXIIIA incubation with its physiological partner, the protease thrombin, led to a monomeric state as well. AUC studies of partially cleaved FXIIIA further suggested that thrombin cleavage of a single activation peptide in a zymogen dimer is sufficient to weaken intersubunit interactions, initiating the transition to monomer. The enzymatic activity of the thrombin-cleaved species was higher than nonproteolytically activated enzyme, suggesting that displacement of the activation peptide renders the FXIIIA more accessible to substrates. Thus, results provide evidence that FXIII undergoes a change in oligomerization state as part of the activation process, and emphasize the role of the activation peptide in preventing FXIIIA catalytic activity.
Introduction
Factor XIII (FXIII) plays a critical role in blood coagulation by covalently cross-linking fibrin c-and a-chains into a fibrin clot along with inhibitors of fibrinolysis. The significance of FXIII in hemostasis is well recognized, and evidence is growing for the involvement of this enzyme in other physiological exposing catalytically active transglutaminase [7] . In contrast, intracellular FXIIIA 2 undergoes slow nonproteolytic activation by Ca 2+ [8] [9] [10] . In vitro, FXIIIA 2 can be activated by thrombin in essentially the same manner as plasma FXIII A 2 B 2 , but without involvement of the B-subunits. Cleavage of a single activation peptide in the dimeric zymogen FXIIIA 2 has been reported to promote exposure of active sites on both subunits, yielding full enzymatic activity of such a 'single-cleaved' dimer [11] . In addition, both plasma and cellular FXIII can be activated in the presence of nonphysiologically high (> 50 mM) Ca 2+ [12] . Ca 2+ has been demonstrated to be crucial for transglutaminase activity, whereas other divalent cations are much less effective (Ca 2+ >Sr 2+ >Ba 2+ >Mg 2+ ) [13] . Furthermore, the binding of Ca 2+ stabilizes FXIIIA preventing its premature degradation by proteases [14] .
Although both active sites in FXIIIA 2 are exposed upon activation by thrombin, previous inhibition studies [11, 12, 15] revealed that only one mole of radiolabeled iodoacetamide (IAA) was incorporated per two moles of thrombin-activated A-subunits (half-of-thesites reactivity), thus negative cooperativity was proposed for the catalytic action of FXIIIA. Interestingly, no large differences between the zymogen and thrombin-activated forms were observed in early X-ray crystal studies [16, 17] . However, with a FXIIIA-catalyzed reaction where two polypeptide chains are cross-linked, significant rearrangements in the enzyme would be required to bind substrate and to release the product. Indeed, solution-based hydrogen-deuterium exchange and chemical modification experiments indicated conformational alterations with opening of the FXIIIA dimer interface upon activation [18] [19] [20] . Consistent with those conclusions, nonproteolytically activated FXIIIA that had been covalently inhibited was later crystallized with an exposed active site and proposed to be monomeric [21] . In addition, recent in silico steered molecular dynamics simulations have suggested a weakening of intersubunit interactions in both nonproteolytically and proteolytically activated FXIIIA [22] .
In the present work, we address the oligomeric state of the A-subunits of FXIII in a solution environment. We demonstrate that the dimeric FXIIIA zymogen dissociates upon nonproteolytic activation. For the first time, to our knowledge, direct experimental evidence is presented for the monomeric state of thrombin-activated FXIIIA. Our results suggest that the cleavage of one activation peptide in a zymogen FXIIIA 2 weakens intersubunit interactions, likely leading to subsequent dissociation of the dimer. Furthermore, displacement of the activation peptide from the A-subunits of FXIII provides better accessibility of the enzyme to its substrates.
Results
Activated FXIIIA species experience significant conformational rearrangement compared to the zymogen form
In an attempt to probe FXIIIA for possible conformational rearrangements in solution upon activation, we performed intrinsic tryptophan fluorescence measurements ( Fig. 2A) . To activate FXIIIA proteolytically (by cleavage of the activation peptide), the zymogen was incubated with thrombin in the presence of 4 mM Ca 2+ . Nonproteolytic activation was achieved in the presence of 100 mM Ca
2+ . An overall fluorescence decrease was observed for activated FXIIIA forms relative to the zymogen, suggesting an increase in polarity of the environment surrounding some of the tryptophan residues in the FXIIIA molecule. Thus, we speculated that these tryptophan residues became more solvent exposed, indicating conformational rearrangements in the A 2 -homodimer. As a control, FXIIIA was also treated with 100 mM Mg 2+ , and no effect on intrinsic fluorescence of the protein was detected.
To further assess possible dissociation of FXIIIA upon activation, a series of nondenaturing polyacrylamide gel electrophoresis (nPAGE) experiments was conducted. A significant change in FXIIIA electrophoretic mobility was visible upon activation by thrombin (Fig. 2B, lane 2) and by 100 mM Ca 2+ (Fig. 2B, lane 3) . However, these conditions caused the protein to spread along a migration path (especially in thrombin-activated FXIIIA), yielding no well-defined bands on the gel. In contrast, the migration of FXIIIA treated with 100 mM Mg 2+ (Fig. 2B, lane 4) was identical to that of the zymogen form (Fig. 2B, lane 1) .
Finally, FXIIIA was analyzed by size exclusion chromatography (SEC, Fig. 2C ). Both zymogen and 100 mM Mg 2+ -treated FXIIIA had similar elution profiles. Their Stokes radii were determined to be 5.0 and 4.8 nm, respectively. In the presence of 100 mM Ca 2+ , FXIIIA eluted after the zymogen form (Fig. 2C) , and its Stokes radius was 3.5 nm. These observations are consistent with the possibility of dissociation of FXIII A 2 -homodimer upon nonproteolytic activation.
FXIIIA 2 dissociates into monomers upon activation
Although fluorescence measurements, nPAGE, and SEC results indicated significant perturbations in FXIIIA upon activation, the oligomerization states of the enzyme forms remained inconclusive. In contrast, analytical ultracentrifugation (AUC) provided distinct resolution of the FXIIIA species. Representative results of sedimentation velocity analyses are summarized in Table 1 and Fig. 3 . We confirmed the dimeric state of FXIIIA zymogen in solution (Fig. 3, trace i) . The sedimentation coefficient of~7.9 S was consistent with the molecular weight of~160 kDa. A frictional ratio of~1.3 indicated a slightly asymmetric molecule. In the presence of 100 mM Mg 2+ , 90% of the protein existed in the dimeric form (Fig. 3, trace iii) . A profound change in sedimentation properties was observed in the presence of 100 mM Ca 2+ (Fig. 3 , trace ii). This nonproteolytically activated FXIIIA migrated uniformly with a sedimentation coefficient of 4.8 S, consistent with the molecular weight 80 kDa, thus indicating a monomeric state. A more detailed analysis of the nonproteolytically activated FXIIIA oligomeric state is presented later in this manuscript, along with activity studies.
Analytical ultracentrifugation of thrombin-activated FXIIIA revealed a monomer with a sedimentation coefficient of~4.6 S (Fig. 3, trace iv) . The lower s-value of proteolytically activated FXIIIA compared to the 100 mM Ca 2+ -activated enzyme is consistent with the loss of a 4-kDa activation peptide in the cleaved protein. Although no significant differences could be seen between the frictional ratios of thrombin-cleaved FXIIIA compared to nonproteolytically activated enzyme (Table 1) , the broader peak of the thrombinactivated form (Fig. 3 , trace iv) was suggestive of a more flexible conformation of FXIIIA after activation peptide cleavage. In addition, as previously observed [15, 23] , thrombin-activated FXIIIA tends to aggregate over the course of a few hours, causing its low abundance in solution and thus making it difficult to analyze by both SEC and AUC. Although nondenaturing treatment with sodium deoxycholate or dithiothreitol did not resolve this issue, we did find that the addition of 5% DMSO facilitates solubility of the active FXIIIA (Fig. 3, trace v) . Although this cosolvent decreases the apparent FXIIIA sedimentation coefficient, suggesting an altering of FXIIIA shape, the 5% DMSO does not cause dissociation of zymogen FXIIIA 2 (data not shown) nor does it affect the enzyme catalytic activity (see activity studies below).
Previously published kinetic studies by Hornyak et al. [11] have suggested that only one activation peptide has to be cleaved on the FXIIIA 2 dimer to expose the active sites in both subunits in the presence of Ca
2+
. To assess : 100 lL of 2 lM FXIIIA was applied to a SEC column and elution profiles were recorded for the zymogen form (red), FXIIIA in the presence of 100 mM CaCl 2 (green), and FXIIIA in the presence of 100 mM MgCl 2 (dark blue). Arrows indicate peak elution volumes (V e ) of the calibration standards (i-thyroglobulin, 670 kDa, V e = 7.80 mL; ii-bovine c-globulin, 158 kDa, V e = 8.40 mL; iii-chicken ovalbumin, 43 kDa, V e = 9.87 mL; iv-equine myoglobin, 17 kDa, V e = 11.89 mL); calculation of Stokes radii (R S ) for FXIIIA forms based on their partition coefficients (r): inverse error function of 1Àr (erf À1 (1Àr)) was plotted (right) versus Stokes radii (R S ) for the calibration standards (triangles, i -thyroglobulin, R S = 8.6 nm; ii-bovine c-globulin, R S = 5.1 nm; iii-chicken ovalbumin, R S = 2.8 nm; iv-equine myoglobin, R S = 1.9 nm). Using the calibration line, the R S -values were calculated for FXIIIA samples (circles): zymogen (red, R S = 5.0 nm), FXIIIA treated with 100 mM MgCl 2 (dark blue, R S = 4.8 nm), and FXIIIA in the presence of 100 mM CaCl 2 (green, R S = 3.5 nm).
the oligomerization state of this 'single-cleaved' FXIIIA, activation conditions were adjusted so that approximately half of the A-subunits were cleaved by thrombin (Fig. 4A) . A series of samples was prepared, and some of them were supplemented with 5% DMSO. Representative AUC results for these 'half-cleaved' samples are depicted on Fig. 4C . From a quantitative analysis of sedimentation velocity data of one of the samples (without DMSO), 48% of the protein appeared as a monomer, 42% was a dimer, and 10% formed a large aggregate. Another sample was supplemented with 5% DMSO, and no aggregation was observed yielding 62% monomer and 38% dimer. Assuming random cleavage by thrombin, the resulting distribution of species in these samples ( Fig. 4B ) would be~25% A 2 (noncleaved zymogen) : 50% AʹA ('single-cleaved') : 25% Aʹ ('double-cleaved'). Hence, the 'double-cleaved' species would constitute~25% of monomers in the samples. Our observation of 48% (with no DMSO) and 62% (in the presence of 5% DMSO) monomeric protein can be accounted for by assuming dissociation of a major portion of the 'single-cleaved' FXIIIA dimers. To quantitatively assess intersubunit interactions in FXIIIA, we performed a series of sedimentation equilibrium AUC experiments. Representative distribution profiles obtained for the zymogen and activated forms at three different rotor speeds are presented in Fig. 5 . Global fitting of experimental data to a monomerdimer equilibrium model yielded apparent dissociation constants (K D ) for dimerization of FXIIIA. As expected, interactions of the A-subunits in the zymogen form were relatively tight (K D = 8 nM). Much higher K D -values (weaker interactions) were observed upon activation: 90 mM for nonproteolytically activated and 220 mM for thrombin-activated FXIIIA. Obtained at much lower centrifugal force than that used in the sedimentation velocity experiments, sedimentation equilibrium results provide critical support that activated FXIIIA is likely to exist in monomeric form at physiological concentrations.
Activated FXIIIA remains monomeric upon binding of substrate analogs
To study possible structural rearrangements in the active FXIIIA upon binding substrate analogs, thrombin-activated enzyme was subjected to alkylation of the active site C314 by the thiol reagent IAA. As another test candidate, a peptide inhibitor K9-DON (
, where glutamine is replaced with its isostere 6-diazo-5-oxo-norleucine [18] was used to target the FXIIIA catalytic site region. These two covalent FXIIIA inhibitor adducts resemble an acyl-enzyme intermediate transiently formed during the transglutaminase reaction. In the AUC experiments, both FXIIIA-IAA and FXIIIA-K9-DON complexes appeared as monomers with no significant differences in the sedimentation properties compared to thrombin-activated free enzyme (Fig. 6) .
Comparison of catalytic activities of proteolytically and nonproteolytically activated FXIIIA Transglutaminase activity of FXIIIA under different activation conditions was compared using a coupled spectrophotometric assay (Fig. 7) . In AUC studies, 5% DMSO facilitated solubility of thrombin-cleaved FXIIIA, however, this cosolvent caused a slight decrease in apparent sedimentation coefficient of the protein (Fig. 3) . Thus, the conformation of FXIIIA could be affected by DMSO and hence, catalytic activity. However, as seen from Fig. 7 (ii), addition of 5% DMSO did not affect transglutaminase activity of the thrombin-cleaved FXIIIA. The activity of samples with half of the Asubunits cleaved by thrombin (Fig. 7, iii) was~75% of that observed with the fully cleaved FXIIIA. Enzyme activated in the presence of 100 mM Ca 2+ yielded 25% activity (Fig. 7, iv) as compared to the thrombin-activated FXIIIA. Finally, in the presence of control 100 mM Mg 2+ no detectable activity was observed (Fig. 7, v) , consistent with previous conclusions that among divalent cations, Mg 2+ was the least efficient in supporting FXIIIA transglutaminase activity [19] .
For a more detailed assessment of FXIIIA nonproteolytic activation, the protein was treated in the presence of different concentrations of Ca 2+ . The samples were then subjected to AUC. The resultant sedimentation velocity data were used to quantitate the amount of FXIIIA monomers depending on the concentration of Ca 2+ and to plot a 'titration curve' (Fig. 8 , green line). As expected, increasing Ca 2+ concentrations resulted in an increase in the number of monomers. The sigmoidal shape of the 'titration curve' indicated cooperative Ca 2+ binding to FXIIIA, consistent with previous computational predictions [22] . Transglutaminase activity was also measured for each Ca 2+ concentration (Fig. 8, green triangles) . The most FXIIIA catalytic activity (~35%, compared to the thrombincleaved FXIIIA) was observed in the presence of 50 mM Ca 2+ , followed by a slight decline.
Discussion
Oligomeric assemblies of proteins, particularly those of enzymes, attracted the attention of investigators as soon as it was realized that such assemblies regulate protein function [24] . With continuing advances in experimental techniques and instrumentation, the scope of protein oligomerization research has expanded significantly. It has been estimated [25] that 60% of enzymes form oligomers. Many of these enzymes exist as monomers but require self-association to fulfill the catalytic function. In contrast, the spotlight of the current project is on a protein that is inactive in its oligomeric form. In this work, we evaluated the oligomerization state of the A-subunits of FXIII in relation to their catalytic activity under different conditions in a solution. Intrinsic tryptophan fluorescence profiles and electrophoretic mobilities of both proteolytically and nonproteolytically activated forms of FXIIIA were different from that of the control zymogen, suggesting significant perturbations to the protein upon activation. However, our attempt to resolve proteolytically and nonproteolytically activated FXIIIA using nPAGE encountered difficulties and did not yield defined protein bands on the gels. In contrast, similar experiments with homologous monomeric Transglutaminase 2 demonstrated two different forms. In nPAGE [26] as well as capillary electrophoresis [27] studies, the high mobility (compact conformation) and the low mobility (extended conformation) species were observed. These species were correlated with the crystal structures of inactive and active enzyme, correspondingly.
A reasonable explanation for our nPAGE results is that during separation in an electric field Ca 2+ ions would be migrating in the opposite direction from the negatively charged protein, constantly 'washing out' from the samples. Interestingly, the activation of FXIIIA by high concentrations of Ca 2+ was previously shown to be a reversible process: loss of catalytic activity was observed upon removal of the Ca 2+ ions from FXIIIA, and the protein could be reactivated again by addition of Ca 2+ [28] . Thus, nPAGE results in the current study indicate that presumably monomeric, activated FXIIIA might reassociate into zymogen-like dimers or higher order aggregates upon loss of Ca 2+ ions. Such reassociations have been proposed by Gupta et al. [22] . These phenomena observed in our nPAGE studies occurred specifically in the presence of Ca 2+ but not Mg 2+ , adding to the evidence that Ca 2+ is critical for maintaining the conformation of active FXIIIA.
Size exclusion chromatography analysis indicated different sizes (Stokes radii) of zymogen FXIIIA and its activated form. However, FXIIIA is not an ideal globular protein (Fig. 1A) , and we were cautious about correlating SEC data with molecular weights of FXIIIA forms. In contrast, the AUC approach provided information on the molecular weight and the shape of the protein in solution. The results of sedimentation velocity AUC experiments confirmed the dimeric state of zymogen FXIIIA 2 and its asymmetric shape, in accordance with existing crystal structures and ultracentrifugation studies by Bishop et al. [29] . FXIIIA activated proteolytically by thrombin in the presence of low (4 mM) Ca 2+ appeared as a monomer. Compared to the nonproteolytically Ca 2+ -activated form, the broader sedimentation coefficient peak distribution of thrombin-cleaved FXIIIA indicated its more flexible conformation. Additionally, sedimentation equilibrium AUC provided an effective strategy to quantitatively characterize intersubunit interactions of FXIIIA forms. The apparent dissociation constant for the zymogen FXIIIA was in the nanomolar range, whereas the value increased into the millimolar range for the activated FXIIIA. In platelets, an established reference interval for FXIII A 2 is 46-82 fg per platelet [6] ; given the mean platelet volume of 9 fL [30] , the concentration of the A-subunits is 61-110 lM. The concentration of FXIII A 2 B 2 in plasma is 14-28 mgÁL À1 [4] , corresponding to 86-172 nM of the Asubunits. During a coagulation event, activated FXIII is mobilized at the clotting site and its local concentration may exceed regular plasma levels, however, the amount would not be expected to reach high millimolar values. Thus, the observed drastic weakening of intersubunit interactions supports our concept of dissociation of FXIIIA upon activation at physiological concentrations. Since dissociation of the B-subunits from the A-subunits after cleavage of the activation peptide has been well documented [1, 2] , the physiological presence of FXIIIB is not predicted to significantly affect postcleavage rearrangements of FXIIIA in plasma. An observation of monomeric, thrombin-activated FXIIIA is contrary to previously reported results. concentration. Two micromolar FXIIIA was incubated in the presence of 4-100 mM CaCl 2 for 30 min at 37°C. Samples were then subjected to sedimentation velocity AUC, and quantitation of monomeric species was performed for each sample (green line). AUC runs were performed with at least two independently made samples for each condition studied. In parallel, transglutaminase activity of FXIIIA with different CaCl 2 concentrations was determined using a coupled spectrophotometric assay (green triangles, values are presented as mean AE SD (n = 3). The % activity is compared to thrombin-activated FXIIIA (100%)).
Chung et al. [15] performed AUC of both plasma (A 2 B 2 ) and platelet (A 2 ) FXIII using 50 mM sodium citrate buffer. A valid concern from the Chung study is that most of the added (10 mM) Ca 2+ may have been chelated by citrate. Under their conditions, the dissociation of B 2 -dimer from the A 2 -dimer had occurred, but no evidence for the presence of monomeric FXIIIA either in plasma or platelet-derived enzyme was obtained, much like in our nPAGE efforts. In the present study, no chelating agents were used in the buffers, thus 4 mM Ca 2+ present in the samples was available for binding and stabilizing monomeric thrombin-cleaved FXIIIA [14] .
In an X-ray crystal study, Yee et al. [17] reported no significant changes in structure of FXIIIA after activation with thrombin. However, noncleaved FXIIIA zymogen was present in their crystallographic samples, which was described as a 'minor component' (< 20%). Since thrombin-cleaved FXIIIA is prone to precipitation especially at the high concentrations (10 mgÁmL
À1
) used, the Yee group may have actually crystallized the 'minor component', zymogen FXIIIA, instead of the thrombin-cleaved form.
In samples where half of the FXIIIA subunits were cleaved by thrombin, we observed~75% activity compared to the 'fully cleaved' FXIIIA, in agreement with previously published data [29] . Intuitively, one would expect~75% monomers in such a sample if all 'single-cleaved' species became monomers (Fig. 4B ). Yet our analysis revealed 48% (with no DMSO) and 62% (with 5% DMSO) monomeric protein, thus indicating that some of the 'single-cleaved' species remained dimeric at the concentrations and solution conditions employed in this work. Our present results therefore indicate significant weakening of intersubunit interactions in dimeric FXIIIA 2 upon cleavage of a single activation peptide by thrombin.
Intracellular FXIIIA has been reported to undergo nonproteolytic activation by Ca 2+ ions [9, 10] . To imitate this activation pathway in the current work, FXIIIA was treated with Ca 2+ . Sedimentation velocity experiments revealed increasing dissociation of FXIIIA dimer in the presence of increasing Ca 2+ concentrations (Fig. 8) . Intriguingly, the catalytic activity of nonproteolytically activated species was lower than that of thrombin-activated form. We found no previous reports comparing activities of plasma and cellular forms of FXIII and more in-depth evaluation of the catalytic behavior of nonproteolytically activated FXIIIA is needed to better understand this phenomenon. Our results do, however, suggest that with the activation peptide still present, the A-subunits of FXIII are less accessible to the substrate. The high mM concentrations of Ca 2+ used in the current work to nonproteolytically activate FXIIIA within a reasonable time scale (30 min), would not be physiologically available. Thus, it is reasonable to expect much slower rate of nonproteolytic FXIIIA activation in vivo. In addition, a portion of the intracellular FXIIIA population may exist as nondissociated species, or weak dimers as computationally predicted by Gupta et al. [22] .
In earlier experiments employing radiolabeled IAA [11, 12, 15] , it was found that only half of the possible catalytic sites underwent alkylation, thus half-of-thesites reactivity was postulated for the enzyme, implying its dimeric state. Upon observing active FXIIIA as a monomer in the present study, we considered the possibility of reassociation of the two active A-subunits upon binding an inhibitor to one of them. To test this possibility, activated FXIIIA was modified with IAA or the more substrate-like peptide K9-DON to form covalent adducts with the active site C314 that mimic the acyl-enzyme complex. No dimerization was observed in sedimentation velocity analyses of both inhibited FXIIIA species. While we have no reason to dispute previous findings of the Folk [15] and Shafer [11, 12] research groups on half-of-the-sites reactivity of FXIIIA, there is an obvious need for a detailed study of possible cooperativity in FXIIIA-mediated catalysis.
Our current findings not only contribute to understanding the structure and function relationship in FXIIIA but also provide insight on the protein regulation. Dissociation of the homodimer is likely crucial for FXIIIA cross-linking activity since the active site of each A-subunit must be sufficiently accessible for binding of the two large polypeptide substrates, and, more importantly, for release of the cross-linked product. Upon local elevations of Ca 2+ concentration (e.g., during activation of platelets), the intracellular FXIIIA dissociates and exhibits cross-linking activity, while depletion of Ca 2+ inactivates the enzyme, possibly causing reassociation of the A-subunits or formation of higher order aggregates. In plasma, upon initiation of the coagulation cascade, FXIII is cleaved by thrombin. In this case, low Ca 2+ concentration is sufficient to cause the dissociation of enzyme. Subsequently, monomeric plasma FXIIIA is deactivated proteolytically [31, 32] .
The dimeric state of the zymogen form may thus be viewed as a way to stabilize the protein in a physiological setting. In the FXIIIA dimer, the outer, solventexposed parts are formed mainly by b-sheet structural elements that are less susceptible to proteolytic degradation, while the more vulnerable a-helical structures are shielded within the dimer interface (Fig. 1A) . At the same time, the active sites in the dimeric zymogen are buried, thus preventing undesirable protein crosslinking. Interestingly, a few naturally occurring mutants causative of severe FXIIIA deficiency [33] [34] [35] [36] were predicted to be unable to dimerize and thus susceptible to proteolytic degradation.
To summarize briefly, current research provides experimental insight into FXIIIA oligomeric states in solution. For the first time to our knowledge, homodimeric FXIII A 2 was demonstrated to dissociate as a part of the activation process, and intersubunit interactions were quantitatively assessed. The study also highlights the role of the activation peptide in suppressing FXIIIA transglutaminase activity. This series of findings is intended to provide a better understanding of FXIIIA function as an intra-and extracellular transglutaminase. ). All samples of inhibited FXIIIA contained 5% DMSO.
Experimental procedures
Control samples of zymogen FXIIIA (2 lM) were made in PBS (10 mM Phosphate, 150 mM NaCl, pH 7.4) [29] or in borate buffer.
AUC
The oligomerization and hydrodynamic properties of zymogen as well as activated FXIIIA were studied by analytical ultracentrifugation. Samples were subjected to centrifugation within 2 h of preparation.
Sedimentation velocity experiments were carried out in a Beckman Coulter ProteomeLab XL-A analytical ultracentrifuge (Beckman Coulter Inc., Indianapolis, IN, USA) at 20°C and 50 000 rpm in standard 2 sector cells. Buffer density was determined on a Mettler/Paar Calculating Density Meter DMA 55A at 20.0°C and viscosity was measured using an Anton Parr AMVn Automated Microviscosimeter at 20°C. Data were analyzed with the program SEDFIT (www.analyticalultracentrifugation.com) using the continuous c(s) distribution model. The partial specific volume of FXIIIA was calculated from the amino acid composition (0.734 mLÁg À1 ) using the Protparam tool (www.expasy.org). Frictional ratios were calculated by SEDFIT assuming no bound water. Experimental sedimentation coefficients were corrected to s 20,w using the corrections based on the measured density and viscosity. Analytical runs were performed with at least two independent samples for each condition examined. Sedimentation equilibrium experiments were carried out in standard 2 sector cells using 150 lL of buffer in the reference sector and 130 lL of sample in the sample sector. Three different rotor speeds were used and equilibrium was confirmed by observing the identical distribution of 280 nm absorbance in three successive scans at 2-h intervals for each rotor speed. Data were analyzed using the program SEDPHAT (www.analyticalultracentrifugation.com). Global analysis was carried out using the monomer-dimer selfassociation model and allowing the values of Ka, molecular weight and cell bottom and meniscus to float. Error analysis was performed using the Monte-Carlo error analysis feature of SEDPHAT with 1000 iterations.
Intrinsic tryptophan fluorescence measurements
Fluorescent spectra were collected using a Perkin Elmer LS55 spectrofluorimeter (Waltham, MA, USA). FXIIIA samples were prepared in the same manner as for the AUC. Prior to the measurements, each sample (500 lL) was transferred into a 4.0-mL quartz cuvette and diluted with corresponding buffer to give final volume 2.0 mL (thus giving final FXIIIA concentration of 500 nM). Samples were excited at 280 nm, and emission spectra at 300-400 nm were recorded. Fluorescence measurements were conducted with two independent samples for each condition studied.
nPAGE Samples of FXIIIA were prepared similar to the AUC studies but in smaller volumes (20-100 lL). Samples were then supplemented with a loading buffer (0.5 M tris, pH 6.8; 20% glycerol, 0.01% w/v bromophenol blue) in a 2 : 1 sample : buffer ratio. Electrophoretic separation was conducted at room temperature in a Tris-Glycine running buffer without SDS using 4% stacking and 7.5% resolving gels. During electrophoresis, the temperature of the running buffer did not elevate above 28°C. Gels were stained with Coomassie Blue. At least three independent samples were prepared for each condition studied, with essentially the same results.
SEC
Size exclusion chromatography was performed using a 10 9 300 mm Superdex 75 analytical column (GE Healthcare, Marlborough, MA, USA) on an Akta FPLC (GE Healthcare). The column was calibrated with gel filtration standard from BioRad containing proteins of known Stokes radii (R S ): bovine c-globulin (150 kDa, R S = 5.1 nm), chicken ovalbumin (43 kDa, R S = 2.8 nm), and equine myoglobin (17 kDa, R S = 1.9 nm). Dextran Blue and vitamin B 12 were used to determine the void column volume (V 0 ) and the total volume (V t ), respectively. The BioRad standard protein mixture was separated in borate buffer. Samples of zymogen FXIIIA as well as 100 mM Ca 2+ -and 100 mM Mg 2+ -treated FXIIIA were prepared as described for the sedimentation velocity AUC. Concerned about possible precipitation of the thrombinactivated FXIIIA on the analytical column, we did not subject this form to SEC analysis.
For each run, a 100-lL aliquot of 2 lM protein sample was applied to the column that had been pre-equilibrated with corresponding buffer. All protein separations were carried out at 0.5 mlÁmin À1 , room temperature. Protein elution was monitored by absorbance at 280 nm. The peak elution volume (V e ) of each protein was converted to a partition coefficient (r) using the equation
An inverse error function (erf À1 ) was calculated for (1Àr) [37] of each calibration standard and plotted against their Stokes radii (Fig. 2C ). This calibration 'curve' was then used to determine R S for different forms of FXIIIA.
Activity assays
Transglutaminase activity of FXIIIA was determined using a standard coupled spectrophotometric assay as described elsewhere [18, 38, 39] . Briefly, during the transamidation reaction FXIIIA incorporates a primary amine (glycine ethyl ester) into a glutamine-containing K9-peptide with the release of ammonia. Glutamate dehydrogenase utilizes this ammonia along with NADH to convert a-ketoglutarate to glutamate, accompanied by a sigmoidal decrease in absorbance at 340 nm. The reaction velocity was determined as a slope at the steepest part of the curve. This value was corrected by subtraction of NADH oxidation rate observed in the absence of FXIIIA. Activity measurements were performed in triplicates for all conditions employed for AUC experiments.
